Enzo Biochem Inc. filed an 8-K reporting a merger agreement with Bethpage Parent, Inc. on June 23, 2025, where shareholders will receive $0.70 per share in cash. The merger is subject to shareholder approval, expected to be discussed in a meeting following a preliminary proxy statement to be filed within 10 days.